Regional
Department of Aviation Medicine
Drugs and doses59
A–C Acetaminophen, Acetazolamide, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Cefazolin, Ceftriaxone12
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | page 23 |
| Other | adult | 500 mg | PO | not captured | standing | page 23 |
| Other | adult | 500 mg | IV/PO | not captured | standing | page 25 |
| Other | adult | 500 mg | PO | not captured | standing | page 112 |
| Other | adult | 500 mg | IV | not captured | standing | page 112 |
| Other | peds | 10–15 mg/kg | PO | not captured | standing | page 112 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 112 |
| Sepsis | adult | 650 mg | PO/PR | not captured | standing | page 55 |
Acetazolamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 125 mg | PO | not captured | standing | pages 40, 113 |
| Other | adult | 250 mg | PO | not captured | standing | pages 40, 113 |
| Other | adult | 250–500 mg | IV/PO | not captured | standing | page 113 |
| Other | peds | 1.25 mg/kg | PO | not captured | standing | pages 40, 113 |
| Other | peds | 2.5 mg/kg | PO | not captured | standing | pages 40, 113 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–100 g | PO | not captured | standing | pages 57, 115 |
| Other | peds | 10–25 g | PO | not captured | standing | pages 57, 115 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 3 mg | not captured | not captured | standing | page 116 |
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 72, 83, 116 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 72, 83, 116 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5–5 mg | NEB | not captured | standing | page 38 |
| Allergic reaction | peds | 0.15 mg/kg | NEB | not captured | standing | page 38 |
| Hyperkalemia | adult | 10 mg | NEB | not captured | standing | pages 31, 117 |
| Respiratory distress | adult | 2.5–5 mg | NEB | not captured | standing | page 53 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 53 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 65, 80, 118 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 65, 80, 118 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 72, 118 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 72, 118 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 162–325 mg | PO | not captured | standing | pages 60, 114 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 121 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 121 |
| Nerve agent exposure | adult | 2.1 mg | IM | not captured | standing | page 121 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | page 45 |
| Other | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 121 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 122 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 122 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 122 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 122 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 123 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 123 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | page 123 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | page 123 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 124 |
| Other | peds | 20–30 mg/kg | IV | not captured | standing | page 124 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV/IO | not captured | standing | page 125 |
| Sepsis | peds | 50–75 mg/kg | IV/IO | not captured | standing | page 125 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Epinephrine, Ertapenem, Etomidate, Fentanyl, Furosemide12
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mg | IV/IM/PO | not captured | standing | page 126 |
| Other | adult | 8 mg | IV/IM/PO | not captured | standing | page 126 |
| Other | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 126 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 25–50 g | IV | not captured | standing | page 127 |
| Hypoglycemia | adult | 10–25 g | IV | not captured | standing | page 127 |
| Hypoglycemia | adult | 15–20 g | PO | not captured | standing | page 127 |
| Hypoglycemia | peds | 10–20 mL/kg | IV | not captured | standing | page 127 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IM | not captured | standing | page 128 |
| Other | adult | 10–20 mg | IV | not captured | standing | page 128 |
| Other | adult | 10–30 mg | IV | not captured | standing | page 128 |
| Other | adult | 5–10 mg | IV | not captured | standing | page 128 |
| Other | peds | 1–2 mg | IV/IM | not captured | standing | page 128 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 129 |
| Other | peds | 0.25 mg/kg | IV | not captured | standing | page 129 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 50 mg | IV | not captured | standing | page 130 |
| Allergic reaction | adult | 25–50 mg | IV/IO/PO | not captured | standing | page 130 |
| Allergic reaction | peds | 6.25 mg | PO | not captured | standing | page 130 |
| Anaphylaxis | adult | 50 mg | IV | not captured | standing | page 130 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 130 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 130 |
| Other | peds | 1–2 mg/kg | IV/IM/PO | not captured | standing | page 130 |
| Other | peds | 1.25 mg/kg | IV/IM | not captured | standing | page 130 |
| Other | peds | 12.5–25 mg | PO | not captured | standing | page 130 |
| Other | peds | 25–50 mg | IV/IO/PO | not captured | standing | page 130 |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | peds | 2–20 mcg/kg | IV/IO | not captured | standing | page 131 |
| Other | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 131 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–20 mcg/kg | IV | not captured | standing | page 132 |
| Other | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 132 |
| Other | peds | 2–20 mcg/kg | IV | not captured | standing | page 132 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.05–0.5 mcg/kg | IV | not captured | standing | page 134 |
| Other | adult | 0.3–0.5 mg | IM/SQ | not captured | standing | page 134 |
| Other | adult | 0.3–0.5 mg | IM | not captured | standing | page 134 |
| Other | adult | 0.5 mL | NEB | not captured | standing | page 134 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 134 |
| Other | peds | 0.01 mg/kg | SQ | not captured | standing | page 134 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 136 |
Ertapenem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 138 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 138 |
| Other | peds | 15 mg/kg | IV/IM | not captured | standing | page 138 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 139 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 139 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mcg/kg | IV | not captured | standing | page 140 |
| Other | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 140 |
| Other | adult | 25–50 mcg | IV/IO | not captured | standing | page 140 |
| Other | peds | 1 mcg/kg | IV | not captured | standing | page 140 |
| Mild to moderate pain | adult | 0.5–1 mcg/kg | IV | not captured | standing | page 140 |
| Mild to moderate pain | adult | 1 mcg/kg | IM/IN | not captured | standing | page 140 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV | not captured | standing | page 140 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 142 |
| Other | adult | 20–40 mg | IV/IM | not captured | standing | page 142 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 142 |
G–L Glucagon, Hydromorphone, Hydroxocobalamin, Ketamine, Ketorolac, Labetalol, Levetiracetam, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IV/IM/SQ | not captured | standing | page 143 |
| Hypoglycemia | peds | 0.5 mg | IV/IM/SQ | not captured | standing | page 143 |
| Other | adult | 2–10 mg | IV | not captured | standing | page 143 |
| Other | peds | 0.05–0.15 mg/kg | IV | not captured | standing | page 143 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV/IO/IN | not captured | standing | page 144 |
| Other | peds | 0.01–0.015 mg/kg | IV/IO/IN | not captured | standing | page 144 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 g | IV/IO | not captured | standing | page 145 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 145 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–2 mg/kg | IV | not captured | standing | page 146 |
| Other | adult | 0.5–2 mg/kg | IV | not captured | standing | page 146 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | page 146 |
| Other | peds | 0.5–2 mg/kg | IV | not captured | standing | page 146 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | page 146 |
| Mild to moderate pain | adult | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 146 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IM/IN | not captured | standing | page 146 |
| Mild to moderate pain | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 146 |
| Mild to moderate pain | peds | 0.5–1 mg/kg | IM/IN | not captured | standing | page 146 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV | not captured | standing | page 25 |
| Other | adult | 15–30 mg | IM | not captured | standing | page 25 |
| Other | adult | 15–30 mg | IV/IM | not captured | standing | page 25 |
| Other | peds | 0.25–0.5 mg/kg | IV | not captured | standing | page 148 |
| Other | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 148 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV | not captured | standing | pages 52, 149 |
| Other | peds | 0.2–1 mg/kg | IV | not captured | standing | pages 52, 149 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1500 mg | IV/IO | not captured | standing | pages 34, 151 |
| Other | peds | 15–25 mg/kg | IV/IO | not captured | standing | pages 34, 151 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 152 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 152 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 152 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg | IV/IM | not captured | standing | page 153 |
| Agitation | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | page 153 |
| Seizure | adult | 4 mg | IV/IM | not captured | standing | pages 54, 153 |
| Seizure | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 54, 153 |
M–O Magnesium Sulfate, Mannitol, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Moxifloxacin, Naloxone, Neostigmine, Nifedipine, Nitroglycerin, Norepinephrine, Ondansetron14
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 154 |
| Other | adult | 2 g | IV | not captured | standing | page 154 |
| Other | adult | 4–6 g | IV | not captured | standing | page 154 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 154 |
| Other | peds | 25–50 mg/kg | IV | not captured | standing | page 154 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 154 |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | IV/IO | not captured | standing | page 155 |
| Other | peds | 0.25–1 g/kg | IV/IO | not captured | standing | page 155 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | page 38 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | page 38 |
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | pages 23, 38 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO | not captured | standing | pages 23, 38 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 53, 156 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV | not captured | standing | pages 53, 156 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IO | not captured | standing | page 157 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 5 mg | IV | not captured | standing | page 158 |
| Other | adult | 5 mg | IV | not captured | standing | page 158 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.05–0.12 mg/kg | IV | not captured | standing | pages 16, 159 |
| Other | peds | 0.1–0.15 mg/kg | IM | not captured | standing | page 159 |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | page 159 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 159 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 159 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–5 mg | IV/IO | not captured | standing | page 160 |
| Other | adult | 2.5–10 mg | IV/IO | not captured | standing | page 160 |
Moxifloxacin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 400 mg | PO | not captured | standing | page 161 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IM/IN/SQ | not captured | standing | page 162 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM/IN/SQ | not captured | standing | page 162 |
Neostigmine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV/IO | not captured | standing | page 45 |
Nifedipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | PO | not captured | standing | page 94 |
| Other | adult | 30 mg | PO | not captured | standing | pages 40, 163 |
| Other | peds | 0.5 mg/kg | PO | not captured | standing | pages 40, 163 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.3–0.4 mg | SL | not captured | standing | pages 52, 164 |
| Other | adult | 0.3–0.4 mg | SL | not captured | standing | page 52 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 60, 164 |
| Other | adult | 1 spray | not captured | not captured | standing | page 164 |
| Other | peds | 0.25–0.5 mcg/kg | IV | not captured | standing | page 164 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | pages 35, 55, 165 |
| Hypotension / shock | peds | 0.05–0.2 mcg/kg | IV/IO | not captured | standing | pages 35, 55, 165 |
| Sepsis | adult | 0.1–0.5 mcg/kg | IV/IO | not captured | standing | pages 55, 70, 88 |
| Sepsis | peds | 0.05–2 mcg/kg | IV/IO | not captured | standing | pages 55, 70, 88 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM/PO/ODT | not captured | standing | pages 33, 51, 168 |
| Nausea / vomiting | peds | 0.15–0.3 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | pages 33, 51, 168 |
| Other | adult | 8 mg | IV | not captured | standing | page 168 |
P–R Phenylephrine, Pralidoxime, Procainamide, Promethazine, Propofol, Rocuronium6
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 0.1–10 mcg/kg | IV | not captured | standing | page 170 |
| Hypotension / shock | adult | 50–100 mcg | IV | not captured | standing | page 170 |
| Hypotension / shock | adult | 50–100 mcg | IV | not captured | standing | page 170 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg/kg | IV | not captured | standing | page 171 |
| Other | adult | 600 mg | IM | not captured | standing | page 171 |
| Other | peds | 10–20 mg/kg | IV | not captured | standing | page 171 |
| Other | peds | 15 mg/kg | IM | not captured | standing | page 171 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–50 mg | IV | not captured | standing | page 172 |
| Other | adult | 20–50 mg | IV | not captured | standing | page 172 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 172 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IM | not captured | standing | page 173 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV/IM | not captured | standing | page 173 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 173 |
| Other | peds | 0.5–1.1 mg/kg | IV/IM | not captured | standing | page 173 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.5–1 mg/kg | IV | not captured | standing | page 174 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 175 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 175 |
S–Z Sodium Bicarbonate, Succinylcholine, Thiamine, Tranexamic Acid, Vasopressin, Vecuronium6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV | not captured | standing | page 176 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 176 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV | not captured | standing | page 176 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 176 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 177 |
| RSI induction | peds | 1.5–2 mg/kg | IV/IO | not captured | standing | page 177 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 178 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | pages 34, 179 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 179 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 13, 35, 36, 94, 179 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | pages 13, 35, 36, 94, 179 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.01–0.04 unit | IV | not captured | standing | page 180 |
| Hypotension / shock | peds | 0.0002–0.002 unit/kg | IV | not captured | standing | page 180 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV | not captured | standing | pages 16, 181 |
| RSI induction | peds | 0.1 mg/kg | IV | not captured | standing | pages 16, 181 |
Cite this
Department of Aviation Medicine, United States EMS Protocol Census. 204 dose entries, effective 2026-10-01.
https://protoquiz.com/census/agencies/department-of-aviation-medicine/
The census is free and not for sale. Only public agencies are named.